Endovascular treatment of XXXX with a Low-profile Visualized Intraluminal Support (LVIS Jr) device.

@entity1 @entity510 @entity439 @entity2473 @entity5487 @entity432 @entity850
OBJECTIVE: To describe the treatment of @entity5487 with the Low-profile Visualized Intraluminal Support Device (LVIS Jr) stent. MATERIALS AND METHODS: The databases of three institutions were retrospectively reviewed. @entity1 who underwent endovascular treatment of @entity5487 using a reconstructive technique where the LVIS Jr stent was totally or partially deployed into the PICA were included in the analysis. Clinical presentation, @entity439 and PICA sizes, procedural complications, and clinical and angiographic follow-up information was recorded and analyzed. RESULTS: Seven @entity1 who underwent endovascular treatment of @entity5487 with an LVIS Jr stent were identified. Four @entity439 were treated in the acute phase of @entity510 ( @entity510 ). There were no symptomatic complications. One @entity1 had @entity2473 distal to the stent as a result of mechanical straightening of the vessel. One @entity1 was treated in the acute phase of @entity510 and required a gycoprotein IIb/IIIa inhibitor after the stent was implanted. This @entity1 needed to be re-treated to complete embolization. All @entity1 had good clinical outcomes (Glasgow Outcome Scale 5). No in-stent @entity850 or @entity432 was seen on short-term angiographic follow-up and the @entity439 were occluded. CONCLUSIONS: This small series suggests that the use of a reconstructive technique with the LVIS Jr stent for the treatment of @entity5487 is feasible, safe and effective in the short term.
